EP0324426A2 - Process for forming super high contrast negative images - Google Patents

Process for forming super high contrast negative images Download PDF

Info

Publication number
EP0324426A2
EP0324426A2 EP89100317A EP89100317A EP0324426A2 EP 0324426 A2 EP0324426 A2 EP 0324426A2 EP 89100317 A EP89100317 A EP 89100317A EP 89100317 A EP89100317 A EP 89100317A EP 0324426 A2 EP0324426 A2 EP 0324426A2
Authority
EP
European Patent Office
Prior art keywords
group
substituted
formula
unsubstituted
nitrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP89100317A
Other languages
German (de)
French (fr)
Other versions
EP0324426A3 (en
EP0324426B1 (en
Inventor
Yoshihiro C/O Fuji Photo Film Co. Ltd. Takagi
Hisashi C/O Fuji Photo Film Co. Ltd. Okada
Morio C/O Fuji Photo Film Co. Ltd. Yagihara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Holdings Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP63003446A external-priority patent/JPH01179940A/en
Priority claimed from JP63003445A external-priority patent/JPH01179939A/en
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Publication of EP0324426A2 publication Critical patent/EP0324426A2/en
Publication of EP0324426A3 publication Critical patent/EP0324426A3/en
Application granted granted Critical
Publication of EP0324426B1 publication Critical patent/EP0324426B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03CPHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00Photosensitive materials
    • G03C1/005Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/06Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with non-macromolecular additives
    • G03C1/061Hydrazine compounds
    • GPHYSICS
    • G03PHOTOGRAPHY; CINEMATOGRAPHY; ANALOGOUS TECHNIQUES USING WAVES OTHER THAN OPTICAL WAVES; ELECTROGRAPHY; HOLOGRAPHY
    • G03CPHOTOSENSITIVE MATERIALS FOR PHOTOGRAPHIC PURPOSES; PHOTOGRAPHIC PROCESSES, e.g. CINE, X-RAY, COLOUR, STEREO-PHOTOGRAPHIC PROCESSES; AUXILIARY PROCESSES IN PHOTOGRAPHY
    • G03C1/00Photosensitive materials
    • G03C1/005Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein
    • G03C1/06Silver halide emulsions; Preparation thereof; Physical treatment thereof; Incorporation of additives therein with non-macromolecular additives
    • G03C1/08Sensitivity-increasing substances
    • G03C1/10Organic substances
    • G03C2001/108Nucleation accelerating compound

Definitions

  • an image forming system having super high contrast (in particular, a gamma ( G) of at least 10) is required for improving the reproduction of continuous tone by dot images or the reproduction of line images.
  • lith developer For this purpose, a specific developer called “lith developer” has hitherto been used.
  • the lith developer consists of hydroquinone as the developing agent and also contains a sulfite as a preservative in the form of an addition product with formaldehyde, whereby the concentration of free sulfite ions is reduced as low as possible (typically below 0.1 moliliter). Accordingly, the lith developer is susceptible to air-oxidation and thus cannot be stored for over 3 days.
  • the pH of the developer must be at least 11.0.
  • the developing agent is liable to be oxidized, the pH is liable to deviate by absorbing C0 2 from the air and stable photographic properties are thus not obtained. Accordingly, a process of obtaining super high contrast images in a developer having a high sulfite ion concentration at a pH below 11.0 has been desired.
  • JP-A-61-167939 the term "JP-A” as used herein mean as "unexamined pubiished Japanese patent application”
  • disulfide compounds in JP-A-61-198147 the term "JP-A” as used herein mean as "unexamined pubiished Japanese patent application”
  • amine series compounds in JP-A-60-140340 are disclosed as contrast enhancing agents.
  • a low-speed, light-sensitive material for safelight use employing a hydrazine compound, and containing a water-soluble rhodium salt, is disclosed in JP-A-60-83038 and 60-162246.
  • the addition of a sufficient amount of rhodium salt to increase the sensitivity obstructs the increase of contrast by the hydrazine compound, whereby the desired sufficiently high contrast images are not obtained.
  • An object of this invention is to provide a process of forming super high contrast images using a developer having a pH of from 9.6 to 11.0 in a system containing a hydrazine compound.
  • Another object of this invention is to provide a process of forming super high contrast images with stable photographic performance using a stable developer.
  • a process for forming super high contrast negative images comprises the steps of: processing a super high contrast negative-type silver halide photographic material comprising a support having formed thereon at least one layer, one of which must be a silver halide emulsion layer, containing therein or in another hydrophilic colloid layer at least one hydrazine derivative and at least one nucleation accelerator represented by formula (la) or (Ib) with a developer having a pH of from 9.6 to 11.0; Y[(A 1 ) p A 2 -B] m (la) M 1 S(X) n A 3 -B (Ib) wherein Y represents a group adsorbing onto silver halide; A 1 represents a divalent linkage group composed of an atom or an atomic group selected from hydrogen, carbon, nitrogen, oxygen, and sulfur; A 2 represents a divalent linkage; A3 represents a divalent linkage group composed of an atom or an atomic group selected from carbon
  • Y represents a group which adsorbs onto silver halide as, for example, a nitrogen-containing heterocyclic group.
  • the compound of formula (la) is shown by formula (II) wherein t represents 0 or the integer 1; [(A 1 ) p A 2 -B] m has the same meaning as in formula (la) described above; and Q represents an atomic group necessary for forming a 5-or 6-membered heterocyclic ring composed of members selected from carbon, nitrogen, oxygen, and sulfur.
  • the heterocyclic ring may be condensed with a carbon aromatic ring or a heteroaromatic ring.
  • heterocyclic ring formed by Q examples include the indazoles, benzimidazoles, benzotriazoles, benzoxazoles, benzthiazoles, imidazoles, thiazoles, oxazoles, triazoles, tetrazoles, azaindenes, pyrazoles, indoles, triazines, pyrimidines, pyridines, and quinolines. These heterocyclic rings may be substituted as indicated below.
  • M 2 represents a hydrogen atom, an alkali metal atom (e.g., sodium and potassium), an ammonium group (e.g., trimethylammonium and dimethylbenzylammonium), or a group capable of being replaced with hydrogen or an alkali metal atom under alkali conditions (e.g., acetyl, cyanoethyl, and methanesulfonylethyl).
  • an alkali metal atom e.g., sodium and potassium
  • an ammonium group e.g., trimethylammonium and dimethylbenzylammonium
  • a group capable of being replaced with hydrogen or an alkali metal atom under alkali conditions e.g., acetyl, cyanoethyl, and methanesulfonylethyl.
  • these heterocyclic rings may be substituted by a nitro group, a halogen atom (e.g., chlorine and bromine), a mercapto group, a cyano group, a substituted or unsubstituted alkyl group (e.g., methyl, ethyl, propyl, t-butyl cyanoethyl, methoxyethyl, and methylthioethyl), a substituted or unsubstituted aryl group (e.g., phenyl, 4-methanesulfonamidophenyl, 4-methylphenyl, 3,4-dichlorophenyl, and naphthyl), a substituted or unsubstituted alkenyl group (e.g., allyl), a substituted or unsubstituted aralkyl group (e.g., benzyl, 4-methylbenzyl, and phenethyl), a substituted or
  • Examples of the divalent linkage group shown by A 1 include:
  • R 1 , R 2 , R 3 , R 4 , Rs, R 6 , R 7 , R 8 , R 3 , and R 10 each represents a hydrogen atom, a substituted or unsubstituted alkyl group (e.g., methyl, ethyl, propyl, and n-butyl), a substituted or unsubstituted aryl group (e.g., phenyl and 2-methylphenyl), a substituted or unsubstituted alkenyl group (e.g., propenyl and 1-methylvinyl), or a substituted or unsubstituted aralkyl group (e.g., benzyl and phenethyl).
  • a substituted or unsubstituted alkyl group e.g., methyl, ethyl, propyl, and n-butyl
  • a substituted or unsubstituted aryl group e.g.,
  • the above divalent structures may be further combined with a straight chain or branched alkylene group preferably having to 1 to 6 carbon atoms and more preferably 1 to 3 carbon atoms (e.g., methylene, ethylene, propylene, butylene, hexylene, and 1-methylethylene) to also comprise A, ,
  • a 2 represents a divalent linkage group such as a straight chain or branched alkylene group (e.g., methylene, ethylene propylene, butylene, hexylene, and 1-methylethylene), a straight chain or branched alkenylene group (e.g., vinylene and 1-methylvinylene), a straight chain or branched aralkylene group (e.g., benzylidene), a straight chain or branched arylene group (e.g., phenylene and naphthylene), etc.
  • a straight chain or branched alkylene group e.g., methylene, ethylene propylene, butylene, hexylene, and 1-methylethylene
  • a straight chain or branched alkenylene group e.g., vinylene and 1-methylvinylene
  • a straight chain or branched aralkylene group e.g., benzylidene
  • arylene group e.g
  • a 1 and A 2 in formula (11) may be further substituted with the groups represented by A 1 and A z .
  • R 11 and R 22 which may be the same or different, each represents a hydrogen atom, a substituted or unsubstituted alkyl, alkenyl group or aralkyl group having from 1 to 30 carbon atoms and these groups may be straight chain groups (e.g., methyl, ethyl, n-propyl, n-butyl, n-octyl, allyl, 3-butenyl, benzyl, and 1-naphthylmethyl), branched groups (e.g., iso-propyl and t-octyl), or cyclic groups (e.g., cyclohexyl).
  • R 11 and R 22 which may be the same or different, each represents a hydrogen atom, a substituted or unsubstituted alkyl, alkenyl group or aralkyl group having from 1 to 30 carbon atoms and these groups may be straight chain groups (e.g., methyl, ethy
  • R 11 and R 12 may combine with each other to form a ring which may contain at least one hetero atom e.g., oxygen, sulfur and nitrogen) so as to form a saturated heterocyclic ring such as pyrrolidyl, piperidyl, morpholino, etc.
  • a hetero atom e.g., oxygen, sulfur and nitrogen
  • substituents for R" and R 12 include a carboxy group, a sulfo group, a cyano group, a halogen atom (e.g., fluorine, chlorine, and bromine), a hydroxy group, an alkoxycarbonyl group having from 1 to 20 carbon atoms (e.g., methoxycarbonyl, ethoxycarbonyl, phenoxycarbonyl, and benzyloxycarbonyl), an alkoxy group having from 1 to 20 carbon atoms (e.g., methoxy, ethoxy, benzyloxy, and phenetyloxy), an aryloxy group having not more than 20 carbon atoms (e.g., phenoxy and p-tolyloxy), an acyloxy group having not more than 20 carbon atoms (e.g., acetyloxy and propionyloxy), an acyl group having not more than 20 carbon atoms (e.g., acetyl,
  • the ammonium group shown by B is generally shown by formula (VIII).
  • R 13 , R 14 , and R 15 have the same meaning as R 11 and R 12 in formula (VII) as described above and Z e represents an anion such as halide ion (e.g., Cl e , Br e and I e ) a sulfonate ion (e.g., trifluoromethanesulfonate ion, p-toluenesulfonate ion, benzenesulfonate ion, and p-chlorobenzenesulfonate ion), a sulfate ion (e.g., ethyl sulfate ion and methyl sulfate ions), a prechlorate ion, a tetrafluoroborate ion, etc.
  • q represents the integer 0 or 1 and when the compound forms an intramolecular salt
  • B is a 5- or 6-membered ring containing at least one nitrogen atom and the ring may have substituents or may be condensed with another ring.
  • the nitrogen containing heterocyclic ring are an imidazolyl ring, a pyridyl ring, and a thiazolyl ring.
  • the substituent for the amino group can be selected from the aforesaid substituents for R 11 and R 12 in formula (VII). At least one of Zi, Z 2 , and Z 3 must have the same meaning as (A 1 ) p A 2 -B.
  • heterocyclic rings may be substituted by the substituents applied to the heterocyclic ring shown by Q in formula (II) as described above.
  • the heterocyclic ring shown by X in formula (Ib) described above is a 5- or 6-membered heterocyclic ring containing at least one of nitrogen, oxygen, selenium, and sulfur and may be condensed with a carbon aromatic ring or a hetero aromatic ring.
  • the heterocyclic ring is preferably aromatic and examples thereof are tetrazole, triazole, thiadiazole, oxadiazole, selenadiazole, imidazole, thiazole, oxazole, benzimidazole, benzthiazole, benzoxazole, benzselenazole, and pyrimidine. Among them, tetrazole and thiazole are particularly preferred.
  • heterocyclic rings may be substituted by the same substituents applied to the heterocyclic rings shown by Q in formula (II).
  • the linkage group shown by A3 may further comprise a linkage group by combinations of A 1 , A 2 and/or an alkinylene group ,
  • the alkali metal shown by M 1 in formula (Ib) includes Na + , K + , Li + , etc.
  • the alkaline earth metal shown by M includes Ca , Mg , etc.
  • the quaternary ammonium salt shown by M 1 has from 4 to 30 carbon atoms and examples thereof include, (CH 3 ) 4 N ⁇ , (C 2 H 5 ) 4 N ⁇ , (C 4 H 9 ) 4 N ⁇ , C 6 H 5 CH 2 N ⁇ (CH 3 ) 3 , and C 16 H 33 N ⁇ (CH 3 ) 3 .
  • examples of the quaternary phosphonium salt include (C 4 H 9 ) 4 P ⁇ , C 16 H 33 P ⁇ (CH 3 ) 3 , and C 6 H 5 CH 2 P ⁇ (CH 3 ) 3 .
  • the group shown by Mi which can be replaced with hydrogen or an alkali metal atom under alkali conditions include an acetyl group, a cyanoethyl group, a methanesulfonylethyl group, etc.
  • nucleation accelerators shown by formulae (Ia) and (Ib) are readily synthesized by the methods described in Berichte der Deutschen Chemischen Deutschen Chemischen Deutschen, 28, 77(1895), ibid., 22, 568 (1889), ibid., 29, 2483(1896), Journal of Chemical Society, 1932, 1806, Journal of The American Chemical Society, 71, 4000-(1949), Advances in Heterocyclic Chemistry, 9, 165(1968), Organic Synthesis, IV, 569(1963), Journal of The American Chemical Society, 45, 2390(1923), Chemische Berichte, 9, 465(1976), JP-A-50-37436 and JP-A-51-3231, U.S.
  • Patents 3,295,976, 3,376,310, 2,585,388, and 2,541,924, JP-B-40-28496, JP-B-43-41353, JP-B-60-29390, JP-B-60-29391, JP-B-60-133061, and JP-B-61-1431 (the term "JP-B” as used herein means an "examined published Japanese patent application")
  • JP-A-50-89034 JP-A-57-202531, JP-A-57-167023, JP-A-57-164735, JP-A-60-80839, JP-A-58-152235, JP-A-57-14836, JP-A-59-162546, JP-A-60-130731, JP-A-60-138548, JP-A-58-83852, JP-A-58-159529, JP-A-59-159162, JP-A-60-217358, and JP-A-61-80238.
  • These accelerators may be used singly or in combination thereof.
  • the hydrazine derivative for use in the present invention includes those having a sulfinyl group as described in U.S. Patent 4,478,928 and the compound shown by formula (IX).
  • R 2 -NHNH-CHO (IX) wherein R 2 represents an aliphatic group or an aromatic group.
  • the aliphatic group shown by R 21 in formula (IX) is preferably an aliphatic group having from 1 to 30 carbon atoms.
  • a straight chain, branched, or cyclic alkyl group having from 1 to 20 carbon atoms is preferred.
  • the branched alkyl group may be cyclized so as to form a saturated heterocyclic ring containing at least one hetero atom.
  • the aforesaid alkyl group may have a substituent such as an aryl group, an aikoxy group, a sulfoxy group, a sulfonamido group, a carbonamido group, etc.
  • Examples thereof are t-butyl, n-octyl, t-octyl, cyclohexyl, pyrrolidyl, imidazolyl, tetrahydrofuryl, and morpholino.
  • the aromatic group shown by R 21 in formula (IX) is a monocyclic or dicyclic aryl group or an unsaturated heterocyclic group.
  • the unsaturated heterocyclic group may be condensed with a monocyclic or dicyclic aryl group to form a heteroaryl group.
  • Examples thereof are a benzene ring, a naphthalene ring, a pyridine ring, a pyrimidine ring, an imidazole ring, a pyrazole ring, a quinoline ring, an isoquinoline ring, a benzimidazole ring, a thiazole ring, and a benzothiazole ring.
  • the groups having a benzene ring are preferred.
  • R 21 is a particularly preferred aryl group.
  • the aryl group or aromatic group shown by R 21 may be substituted.
  • substituents include a straight chain, branched, or cyclic alkyl group (preferably having from 1 to 20 carbon atoms), an aralkyl group (preferably a monocyclic or dicyclic ring the alkyl moiety of which has from 1 to 3 carbon atoms), an alkoxy group (preferably having from 1 to 20 carbon atoms), a substituted amino group (preferably an amino group substituted by an alkyl group having from 1 to 20 carbon atoms), an acylamino group (preferably having from 2 to 30 carbon atoms), a sulfonamido group (preferably having from 1 to 30 carbon atoms) and a ureido group (preferably having from 1 to 30 carbon atoms).
  • R 21 in formula (IX) may have therein a ballast group being usually used to immobilize photographic additives such as couplers, etc.
  • the ballast group is a group having at least 8 carbon atoms and is relatively inert to photographic properties. Examples thereof include an alkyl group, an alkoxy group, a phenyl group, an alkylphenyl group, a phenoxy group, and an alkylphenoxy group.
  • R 21 in formula (IX) may have therein a group for enhancing the adsorption onto the surface of silver halide grains.
  • adsorptive groups include a thiourea group, a heterocyclic thioamido group, a mercaptoheterocyclic group, a triazole group, etc., as disclosed in U.S. Patent 4,385,108.
  • particularly preferred compounds of formula (IX) have therein a group which enhances adsorption onto the surface of silver halide grains.
  • Such adsorptive groups include a thiourea group, a heterocyclic thioamido group, a mercaptoheterocyclic group, a triazole group, etc. as disclosed in U.S. Patent 4,385,108.
  • the preferred substituents for the aryl group or aromatic group shown by R 1 include an amido group, a ureido group, a thiourea group, etc.
  • a sulfonamido group is particularly preferred.
  • the nucleation accelerator and the hydrazine derivative of the present invention are preferably incorporated in a silver halide emulsion layer, but they may also be incorporated in other light-insensitive hydrophilic colloid layers (e.g., protective layer, interlayer, filter layer, antihalation layer, etc.), preferably those adjacent to a silver halide emulsion layer. They may be added in the same layer or different layers.
  • Water soluble compound of formulae (la), (Ib) and (IX) may be added to the hydrophilic colloid solution as an aqueous solution thereof. Conversly, when the compound is sparingly soluble in water, the compound may be added thereto as a solution in an organic solvent which is miscible with water.
  • solvent examples include water, methanol, ethanol, acetone, dimethylformamide, methylcellosolve, etc.
  • the optimal amount of the compounds of formula (la), (Ib) and (IX) are selected according to the grain size and the halogen composition of the silver halide emulsion, the method and extent of chemical sensitization, the relation between the layer(s) in which the compounds are incorporated and a silver halide emulsion, and the kind of an antifoggant.
  • the addition amount of the compound of formula (la) for use in the present invention is preferably from 5 mg/m 2 to 500 mg;m 2 , and 10 mg/m 2 to 250 mg / m 2 is particularly preferred.
  • the addition amount of the compound of formula (Ib) is preferably from 1 mg/m 2 to 250 mg / m 2 , and 3 mg/m 2 to 150 mg/m 2 is particularly preferred.
  • the addition amount of the compound of formula (IX) is preferably from 1 mg/m 2 to 300 mg/m 2 , and 2 mg/m 2 to 200 mg/m 2 is particularly preferred.
  • the compound of formula (IX) wherein R 2' contains therein a group enhancing the adsorption onto the surface of silver halide grains is preferably added in an amount of from 2 mg/m 2 to 100 mg / m 2 .
  • the photographic emulsion for use in the present invention may contain silver bromide, silver iodobromide, silver iodochlorobromide, silver chlorobromide, silver iodide, or silver chloride, but it is preferred that the silver halide contains at least 50 mol% silver chloride.
  • the silver halide grains in the photographic emulsion may have a regular crystal form such as cubic, octahedral, dodecahedral, tetradecahedral, etc.; an irregular crystal form such as sphere, tabular, etc.; or a composite of these crystal forms.
  • the silver halide grains may be composed of a mixture of grains having various crystal forms.
  • the silver halide grains for use in the present invention may have different phase between the inside and the surface layer thereof or may be composed of a uniform phase throughout the whole grain.
  • a cadmium salt a zinc salt, a lead salt, a thallium salt, an iridium salt or a complex salt thereof, rhodium salt or a complex salt thereof, iron salt or a complex salt thereof, etc.
  • a cadmium salt a zinc salt, a lead salt, a thallium salt, an iridium salt or a complex salt thereof, rhodium salt or a complex salt thereof, iron salt or a complex salt thereof, etc.
  • a silver halide solvent e.g., ammonia, potassium rhodanate, and thioethers and thione compounds as described in U.S. Patent 3,271,157, JP-A-51-12360, JP-A-53-82408, JP-A-53-144319, JP-A-54-100717, and JP-A-54-155828
  • a silver halide solvent e.g., ammonia, potassium rhodanate, and thioethers and thione compounds as described in U.S. Patent 3,271,157, JP-A-51-12360, JP-A-53-82408, JP-A-53-144319, JP-A-54-100717, and JP-A-54-155828
  • the silver halide emulsion for use in the present invention may or may not be chemically sensitized.
  • Chemical sensitization for use in the present invention include a sulfur sensitization method using active gelatin or a sulfur-containing compound capable of reacting with silver (e.g., thiosulfates, thioureas, mercapto compounds, and rhodanines); a reduction sensitizing method using a reducing material e.g., stannous salt, amines, hydrazine derivatives, formamidinesulfinic acid, silane compounds, etc.); a noble metal sensitization method using a metal compound (e.g., gold complex salts and complex salts of noble metals belonging to group VIII of the Periodic Table, such as Pt, Ir, Pd, etc.); or a combination thereof.
  • a sulfur sensitization method using active gelatin or a sulfur-containing compound capable of reacting with silver e.g., thiosulfates, thioure
  • the silver halide emulsions for use in this invention can contain various compounds for preventing the formation of fog during the storage and/or photographic processing of the light-sensitive material or for stabilizing photographic performance.
  • antifoggants or stabilizers include azoles (e.g., benzothiazoliums, nitroindazoles, triazoles, benzotriazoles, benzimidazoles (in particular, nitro- or halogen- substituted benzimidazoles)); heterocyclic mercapto compounds (e.g., mercaptothiazoles, mercaptobenzothiazoles, mercaptobenzimidazoles, mercaptothiadiazoles, mercaptotetrazoles (in particular, 1-phenyl-5-mercaptotetrazole), and mercaptopyrimidines), the aforesaid heterocyclic mercapto compounds having a water-solubilizing group such as a carboxy group and a sulfon group
  • ox- azolinethione ox- azolinethione
  • azaindenes e.g., tetraazaindenes (in particular, 4-hydroxy-substituted (1.3,3a.7)-tetraazaindenes
  • benzenethiosulfonic acids e.g., benzenethiosulfonic acids, and benzenesulfinic acid.
  • the photographic emulsion for use in the present invention may be spectrally sensitized to relatively a long wavelength of blue light, green light, red light, or infrared light using sensitizing dyes.
  • sensitizing dyes include cyanine dyes, merocyanine dyes, complex cyanine dyes, complex merocyanine dyes, holopolar cyanine dyes, styryl dyes, hemicyanine dyes, oxonol dyes, hemioxonol dyes, etc.
  • the photographic light-sensitive material being processed in the present invention may contain water-soluble dyes in the hydrophilic colloid layer(s) as filter dyes or for irradiation inhibition, etc.
  • dyes include oxonol dyes, hemioxonol dyes, styryl dyes, merocyanine dyes, cyanine dyes and azo dyes.
  • oxonol dyes, hemioxanol dyes, and merocyanine dyes are particularly useful.
  • the photographic light-sensitive material of the present invention may further contain in the photographic emulsion layer(s) and other hydrophilic colloid layer(s) an inorganic or organic hardening agent.
  • an inorganic or organic hardening agent e.g., active vinyl compounds (e.g., 1,3,5-triacryloyl-hexahydro-s-triazine and 1,3- vinylsulfonyl-2-propanol) and active halogen compounds (e.g., 2,4-dichloro-6-hydroxy-s-triazine) can be used singly or as a combination thereof.
  • the photographic light-sensitive material of the present invention may further contain in the photographic emulsion layer(s) or other hydrophilic colloid layer(s) various surface active agents.
  • nonionic surface active agents such as saponin (steroid series), alkylene oxide derivatives (e.g., polyethylene glycol, polyethylene glycolipolypropylene glycol condensates, polyethylene glycol alkyl ethers, polyethylene glycol alkylaryl ethers, polyethylene glycol esters, polyethylene glycol sorbitan esters, polyalkylene glycol alkylamines, polyalkylene glycol alkylamides, and polyethylene oxide addition products of silicone), glycidol derivatives (e.g., alkenyl succinic acid polyglyceride and alkylphenol polyglyceride), aliphatic acid esters of polyhydric alcohols, alkyl esters of saccharide, etc.; anionic surface active agents containing an acid group (e.g., a carboxy group, a sulfo group, a phospho group, a sulfuric acid ester group, and a phosphoric acid ester
  • an acid group e.g.,
  • the photographic emulsion layer(s) of the photographic light-sensitive material of the present invention may further contain polyalkylene oxide or the derivatives thereof such as the ethers, esters, amines, etc., thereof, thioether compounds, thiomorpholines, quaternary ammonium salt compounds, urethane derivatives, urea derivatives, imidazole derivatives, 3-pyrazolidone derivatives, etc., for increasing sensitivity, contrast, and/or accelerating development.
  • polyalkylene oxide or the derivatives thereof such as the ethers, esters, amines, etc., thereof, thioether compounds, thiomorpholines, quaternary ammonium salt compounds, urethane derivatives, urea derivatives, imidazole derivatives, 3-pyrazolidone derivatives, etc.
  • gelatin is advantageously used, but other hydrophilic colloids can also be used.
  • hydrophilic high molecular materials such as polyvinyl alcohol, polyvinyl alcohol partial acetal, poly-N-vinylpyrrolidone, polyacrylic acid, polyacrylamide, dextran, etc. may be used.
  • a stable developer can be used without use of either a conventional infectious developer or a high alkaline developer of about pH 13 as described in U.S. Patent 2,419.975.
  • super high contrast negative images are obtained by processing the light-sensitive material of the present invention with a developer containing a sulfite ion at a concentration of at least 0.15 mol/liter and having pH of from 9.6 to 11.0, and particularly from 10.0 to 11.0.
  • the developing agent which can be used in the process of the present invention and, for example, dihydroxybenzenes (e.g., hydroquinone), 3-pyrazolidones (e.g., 1-phenyl-3-pyrazolidone, 4,4-dimethyl-1-phenyl-3-pyrazolidone), and aminophenols (e.g., N-methyl-p-aminophenol) can be used singly or in combination thereof.
  • dihydroxybenzenes e.g., hydroquinone
  • 3-pyrazolidones e.g., 1-phenyl-3-pyrazolidone, 4,4-dimethyl-1-phenyl-3-pyrazolidone
  • aminophenols e.g., N-methyl-p-aminophenol
  • the silver halide light-sensitive material of the present invention is preferably processed by a developer containing a dihydroxybenzene as the primary developing agent and a 3-pyrazolidone or an aminophenol as an auxiliary developing agent.
  • the developer contain the dihydroxybenzene in the range of from 0.05 to 0.5 mol;liter and the 3-pyrazolidone or aminophenol in the range of less than 0.06 mol/liter.
  • the developer for use in the present invention may further contain pH buffers such as sulfites, carbonates, borates, and phosphates of an alkali metal or a development inhibitors or antifoggants such as bromides, iodides and organic antifoggants (nitroindazoles or benzotriazoles are particularly preferred).
  • the developer may contain a water softener, a resolution aid, a toning agent, a development accelerator, a surface active agent (a polyalkylene oxide is particularly preferred), a defoaming agent, a hardening agent, and or a silver stain inhibitor of films (e.g., 2-mercaptobenzimidazole sulfonic acids).
  • the silver halide light-sensitive material is fixed in the present invention.
  • Ordinary fixing compositions can be employed including thiosulfates, thiocyanates, and organic sulfur compounds which are known to have an effect as fixing agent.
  • the fix solution may contain a water-soluble aluminum salt as a hardening agent.
  • the processing temperature in the process of the present invention is typically from 18° C to 50 C.
  • An automatic processor is preferably used for the photographic processing of the present invention. Even when the total processing time is in the range of from 90 seconds to 120 seconds., negative photographic characteristics of super high contrast are obtained.
  • the developer for use in the present invention may contain the compound disclosed in JP-A-56-24347 as a silver stain inhibitor. Furthermore, the developer may contain the compound disclosed in JP-A-61-267759 as a resolution aid. Moreover, the developer may further contain the compound disclosed in JP-A-60-93433 or boron compounds disclosed in JP-A-62-186259.
  • a silver chloroiodobromide emulsion (containing 0.1 mol% silver iodide and 30 mol% silver bromide) was prepared using a double jet method as shown below.
  • (NH 4 ) 3 RhCl 6 was added to the aqueous halide solution (containing KBr, NaCt and KI)as a rhodium salt at a concentration of 5x10 -6 mol/mol-Ag.
  • K 3 IrCl 6 was also added to the aqueous halide solution as an iridium salt at a concentration of 4x10 -7 mol/mol-Ag.
  • aqueous halide solution thus prepared and an aqueous silver nitrate solution were added to an aqueous gelatin solution and mixed for 60 minutes at 45°C to provide a mono-dispersed cubic grain size halide having a mean grain size of 0.25 ⁇ m.
  • 1x10 -5 mol/mol-Ag of sodium thiosulfate and 1x10 -5 mol/mol-Ag of potassium chloroaurate were added to the emulsion for gold sensitization.
  • each of IX-9, IX-31, IX-20, IX-32, IX-34, and IX-35 as the hydrazine compound shown by formula (IX) and each of la-15 and Ib-7 as a nucleation accelerator as shown in Table 1 below to provide the silver halide emulsion.
  • a coating composition for a protective layer was composed of an aqueous gelatin solution containing gelatin, sodium dodecylbenzenesulfonate, colloidal silica, a dispersion of polyethyl acrylate, polymethyl methacrylate (matting agents), and sodium polystyrenesulfonate (tackifier).
  • the aforesaid emulsion and the coating composition for the protective layer were simultaneously coated on a transparent plastic film support at a gelatin coverage of 1.6 gim 2 for the protective layer and a silver coverage of 3.6 g/m 2 for the emulsion layer.
  • Each sample thus prepared was exposed to tungsten light of 3200 K through a sensitometric optical wedge for 5 seconds, developed by developer (A) or (D) having the composition shown below for 30 seconds at 38 C, fixed, washed, and dried.
  • An automatic processor FG-660F, made by Fuji Photo Film Co., Ltd. was used for the development processing.
  • Developer (D) was prepared by adding acetic acid to developer (A) reducing the pH to 10.4.
  • Developers (B), (C), (D), (E), (F), and (G) were prepared having the same composition as the developer in Example 1 except that the pH value was adjusted as shown in Table 2.
  • Light-sensitive film prepared as in Sample No. 9 of Example 1 was processed using the developer of Example 1, as adjusted for pH, and the G value was then measured. The results are shown in Table 2.
  • the light-sensitive film was processed using the one week old developer and the G value was measured. The results are also shown in Table 2.

Landscapes

  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • General Physics & Mathematics (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)

Abstract

A process of forming super high contrast negative photographic materials in a developer having a pH of from 9.6 to 11.0 wherein the photographic material contains a hydrazine compound and a nucleation accelerator.

Description

    BACKGROUND OF THE INVENTION
  • In the field of graphic arts, an image forming system having super high contrast (in particular, a gamma ( G) of at least 10) is required for improving the reproduction of continuous tone by dot images or the reproduction of line images.
  • For this purpose, a specific developer called "lith developer" has hitherto been used. The lith developer consists of hydroquinone as the developing agent and also contains a sulfite as a preservative in the form of an addition product with formaldehyde, whereby the concentration of free sulfite ions is reduced as low as possible (typically below 0.1 moliliter). Accordingly, the lith developer is susceptible to air-oxidation and thus cannot be stored for over 3 days.
  • Methods of obtaining high contrast and high sensitivity photographic characteristics using a stable developer and hydrazine derivatives are described in U.S. Patents 4,224,401, 4,168,977, 4,166,742, 4,311,781, 4,272,606, 4,211,857, 4,243,739, etc. Furthermore since sulfite can be added at a high concentration, the stability of the developer to air oxidation is greatly improved as compared to the lith developer.
  • However, for forming super high contrast images using a hydrazine derivative, the pH of the developer must be at least 11.0. In such circumstances, the developing agent is liable to be oxidized, the pH is liable to deviate by absorbing C02 from the air and stable photographic properties are thus not obtained. Accordingly, a process of obtaining super high contrast images in a developer having a high sulfite ion concentration at a pH below 11.0 has been desired.
  • A means for increasing the activity of hydrazine has been keenly desired and in this regard, phosphonium salt compounds in JP-A-61-167939 (the term "JP-A" as used herein mean as "unexamined pubiished Japanese patent application"), disulfide compounds in JP-A-61-198147, and amine series compounds in JP-A-60-140340 are disclosed as contrast enhancing agents. However, even by using these compounds, it is difficult to further enhance contrast at a pH below 11.
  • On the other hand, a low-speed, light-sensitive material for safelight use employing a hydrazine compound, and containing a water-soluble rhodium salt, is disclosed in JP-A-60-83038 and 60-162246. However, in this case, the addition of a sufficient amount of rhodium salt to increase the sensitivity obstructs the increase of contrast by the hydrazine compound, whereby the desired sufficiently high contrast images are not obtained.
  • SUMMARY OF THE INVENTION
  • An object of this invention, therefore, is to provide a process of forming super high contrast images using a developer having a pH of from 9.6 to 11.0 in a system containing a hydrazine compound.
  • Another object of this invention is to provide a process of forming super high contrast images with stable photographic performance using a stable developer.
  • It has now been discovered that the aforesaid objectives can be attained by the process of the present invention as set forth below.
  • That is, according to the present invention, a process is provided for forming super high contrast negative images, which comprises the steps of: processing a super high contrast negative-type silver halide photographic material comprising a support having formed thereon at least one layer, one of which must be a silver halide emulsion layer, containing therein or in another hydrophilic colloid layer at least one hydrazine derivative and at least one nucleation accelerator represented by formula (la) or (Ib) with a developer having a pH of from 9.6 to 11.0; Y[(A1)pA2-B]m (la) M1S(X)nA3-B (Ib) wherein Y represents a group adsorbing onto silver halide; A1 represents a divalent linkage group composed of an atom or an atomic group selected from hydrogen, carbon, nitrogen, oxygen, and sulfur; A2 represents a divalent linkage; A3 represents a divalent linkage group composed of an atom or an atomic group selected from carbon, nitrogen, oxygen, and sulfur; B represents an amino group which may be substituted, an ammonium group, or a nitrogen-containing heterocyclic ring; X represents a divalent heterocyclic ring containing a nitrogen atom, oxygen atom, selenium atom, or sulfur atom; M1 represents a hydrogen atom, an alkali metal, an alkaline earth metal, a quaternary ammonium salt, a quaternary phosphonium salt, an amidino group, or a group capable of being released under alkaline conditions; m represents the integer 1, 2, or 3; and n and p each represent 0 or the integer 1,
  • DETAILED DESCRIPTION OF THE INVENTION
  • The compounds for use in the present invention are described in detail.
  • In formula (la) described above, Y represents a group which adsorbs onto silver halide as, for example, a nitrogen-containing heterocyclic group.'
  • When Y represents a nitrogen-containing heterocyclic group, the compound of formula (la) is shown by formula (II)
    Figure imgb0001
    wherein t represents 0 or the integer 1; [(A1)pA2-B]m has the same meaning as in formula (la) described above; and Q represents an atomic group necessary for forming a 5-or 6-membered heterocyclic ring composed of members selected from carbon, nitrogen, oxygen, and sulfur. The heterocyclic ring may be condensed with a carbon aromatic ring or a heteroaromatic ring.
  • Examples of the heterocyclic ring formed by Q include the indazoles, benzimidazoles, benzotriazoles, benzoxazoles, benzthiazoles, imidazoles, thiazoles, oxazoles, triazoles, tetrazoles, azaindenes, pyrazoles, indoles, triazines, pyrimidines, pyridines, and quinolines. These heterocyclic rings may be substituted as indicated below.
  • In formula (II), M2 represents a hydrogen atom, an alkali metal atom (e.g., sodium and potassium), an ammonium group (e.g., trimethylammonium and dimethylbenzylammonium), or a group capable of being replaced with hydrogen or an alkali metal atom under alkali conditions (e.g., acetyl, cyanoethyl, and methanesulfonylethyl).
  • Also, these heterocyclic rings may be substituted by a nitro group, a halogen atom (e.g., chlorine and bromine), a mercapto group, a cyano group, a substituted or unsubstituted alkyl group (e.g., methyl, ethyl, propyl, t-butyl cyanoethyl, methoxyethyl, and methylthioethyl), a substituted or unsubstituted aryl group (e.g., phenyl, 4-methanesulfonamidophenyl, 4-methylphenyl, 3,4-dichlorophenyl, and naphthyl), a substituted or unsubstituted alkenyl group (e.g., allyl), a substituted or unsubstituted aralkyl group (e.g., benzyl, 4-methylbenzyl, and phenethyl), a substituted or unsubstituted alkoxy group (e.g., methoxy and ethoxy), a substituted or unsubstituted aryloxy group (e.g., phenoxy and 4-methoxyphenoxy), a substituted or unsubstituted alkylthio group (e.g., methylthio, ethylthio, and methoxyethylthio), a substituted or unsubstituted arylthio group (e.g., phenylthio), a substituted or unsubstituted sulfonyl group (e.g., methanesulfonyl, ethanesulfonyl, and p-toluenesulfonyl), a substituted or unsubstituted carbamoyl group (e.g., unsubstituted carbamoyl, methylcarbamoyl, and phenylcarbamoyl), a substituted or unsubstituted sulfamoyl group (e.g., unsubstituted sulfamoyl, methylsulfamoyl, and phenylsulfamoyl), a substituted or unsubstituted carbonamido group (e.g., acetamido group and benzamido group), a substituted or unsubstituted sulfonamido group (e.g., methanesulfonamido, benzenesulfonamido, and p-toluenesulfonamido), a substituted or unsubstituted ac- ylaoxy group (e.g., acetyloxy and benzoyloxy), a substituted or unsubstituted sulfonyloxy group (e.g., methanesulfonyloxy), a substituted or unsubstituted ureido group (e.g., unsubstituted ureido, methylureido, ethylureido, and phenylureido), a substituted or unsubstituted thioureido group (e.g., unsubstituted thioureido and methylthioureido), a substituted or unsubstituted acyl group (e.g., acetyl and benzyl), a substituted or unsubstituted heterocyclic group (e.g., 1-morpholino, 1-piperidino, 2-pyridyl, 4-pyridyl, 2-thienyl, 1-pyrazolyl, 1-imidazolyl, 2-tetrahydrofuryl, and tetrahydrothienyl), a substituted or unsubstituted oxycarbonyl group (e.g., methoxycarbonyl and phenoxycarbonyl), a substituted or unsubstituted oxycar- bonylamino group (e.g., methoxycarbonylamino, phenoxycarbonylamino, and 2-ethylhexyloxycar- bonylamino), a substituted or unsubstituted amino group (e.g., unsubstituted amino, dimethylamino, methox- yethylamino, and anilino), a carboxylic acid or a salt thereof, a sulfonic acid or a salt thereof, a hydroxy group, etc.
  • Examples of the divalent linkage group shown by A1 include:
    Figure imgb0002
    Figure imgb0003
    Figure imgb0004
  • In the above formulae. R1, R2, R3, R4, Rs, R6, R7, R8, R3, and R10 each represents a hydrogen atom, a substituted or unsubstituted alkyl group (e.g., methyl, ethyl, propyl, and n-butyl), a substituted or unsubstituted aryl group (e.g., phenyl and 2-methylphenyl), a substituted or unsubstituted alkenyl group (e.g., propenyl and 1-methylvinyl), or a substituted or unsubstituted aralkyl group (e.g., benzyl and phenethyl).
  • The above divalent structures may be further combined with a straight chain or branched alkylene group preferably having to 1 to 6 carbon atoms and more preferably 1 to 3 carbon atoms (e.g., methylene, ethylene, propylene, butylene, hexylene, and 1-methylethylene) to also comprise A, ,
    Figure imgb0005
    Figure imgb0006
    Figure imgb0007
    Figure imgb0008
    Figure imgb0009
  • In formula (II), A2 represents a divalent linkage group such as a straight chain or branched alkylene group (e.g., methylene, ethylene propylene, butylene, hexylene, and 1-methylethylene), a straight chain or branched alkenylene group (e.g., vinylene and 1-methylvinylene), a straight chain or branched aralkylene group (e.g., benzylidene), a straight chain or branched arylene group (e.g., phenylene and naphthylene), etc.
  • A1 and A2 in formula (11) may be further substituted with the groups represented by A1 and Az.
  • The substituted or unsubstituted amino group shown by B in formula (II) is shown by formula (VII).
    Figure imgb0010
    wherein R11 and R22, which may be the same or different, each represents a hydrogen atom, a substituted or unsubstituted alkyl, alkenyl group or aralkyl group having from 1 to 30 carbon atoms and these groups may be straight chain groups (e.g., methyl, ethyl, n-propyl, n-butyl, n-octyl, allyl, 3-butenyl, benzyl, and 1-naphthylmethyl), branched groups (e.g., iso-propyl and t-octyl), or cyclic groups (e.g., cyclohexyl).
  • Also, R11 and R12 may combine with each other to form a ring which may contain at least one hetero atom e.g., oxygen, sulfur and nitrogen) so as to form a saturated heterocyclic ring such as pyrrolidyl, piperidyl, morpholino, etc.
  • Furthermore, substituents for R" and R12 include a carboxy group, a sulfo group, a cyano group, a halogen atom (e.g., fluorine, chlorine, and bromine), a hydroxy group, an alkoxycarbonyl group having from 1 to 20 carbon atoms (e.g., methoxycarbonyl, ethoxycarbonyl, phenoxycarbonyl, and benzyloxycarbonyl), an alkoxy group having from 1 to 20 carbon atoms (e.g., methoxy, ethoxy, benzyloxy, and phenetyloxy), an aryloxy group having not more than 20 carbon atoms (e.g., phenoxy and p-tolyloxy), an acyloxy group having not more than 20 carbon atoms (e.g., acetyloxy and propionyloxy), an acyl group having not more than 20 carbon atoms (e.g., acetyl, propionyl, benzoyl, and mesyl), a carbamoyl group (e.g., carbamoyl, N,N-dimethylcarbamoyl, morpholinocarbonyl, and piperidinocarbonyl), a sulfamoyl group (e.g., sulfamoyl , N,N-dimethylsulfamoyl, morpholinosulfonyl, and piperidinosulfonyl), an acylamino group having not more than 20 carbon atoms (e.g., acetylamino, propionylamino, benzoylamino, mesylamino), a sulfonamido group (e.g., ethylsulfonamido and p-toluenesulfonamido), a carbonamido group having not more than 20 carbon atoms (e.g., methylcarbonamido and phenylcarbonamido), a ureido group having not more than 20 carbon atoms (e.g., methylureido and phenylureido), an amino group (same ones as defined in formula (VII)), etc.
  • The ammonium group shown by B is generally shown by formula (VIII). wherein R13, R14, and R15 have the same meaning as R11 and R12 in formula (VII) as described above and Ze represents an anion such as halide ion (e.g., Cle , Bre and Ie) a sulfonate ion (e.g., trifluoromethanesulfonate ion, p-toluenesulfonate ion, benzenesulfonate ion, and p-chlorobenzenesulfonate ion), a sulfate ion (e.g., ethyl sulfate ion and methyl sulfate ions), a prechlorate ion, a tetrafluoroborate ion, etc. Also, q represents the integer 0 or 1 and when the compound forms an intramolecular salt, q is 0.
  • As a nitrogen-containing heterocyclic ring, B is a 5- or 6-membered ring containing at least one nitrogen atom and the ring may have substituents or may be condensed with another ring. Examples of the nitrogen containing heterocyclic ring are an imidazolyl ring, a pyridyl ring, and a thiazolyl ring.
  • Preferred embodiments of formula (II) are shown by formulae (III), (IV), (V), or (VI);
    Figure imgb0012
    Figure imgb0013
    Figure imgb0014
    Figure imgb0015
    wherein (A1)p-A2-B, M2 and m have the same meaning as defined above in formula (II); Z1, Z2, and Z3 have the same meaning as (A1 )pA2-B in formula(la) or each represents a halogen atom, an alkoxy group having from 1 to 20 carbon atoms (e.g., methoxy), a hydroxy group, a hydroxyamino group, or a substituted or unsubstituted amino group. The substituent for the amino group can be selected from the aforesaid substituents for R11 and R12 in formula (VII). At least one of Zi, Z2, and Z3 must have the same meaning as (A1)pA2-B.
  • These heterocyclic rings may be substituted by the substituents applied to the heterocyclic ring shown by Q in formula (II) as described above.
  • The heterocyclic ring shown by X in formula (Ib) described above is a 5- or 6-membered heterocyclic ring containing at least one of nitrogen, oxygen, selenium, and sulfur and may be condensed with a carbon aromatic ring or a hetero aromatic ring. The heterocyclic ring is preferably aromatic and examples thereof are tetrazole, triazole, thiadiazole, oxadiazole, selenadiazole, imidazole, thiazole, oxazole, benzimidazole, benzthiazole, benzoxazole, benzselenazole, and pyrimidine. Among them, tetrazole and thiazole are particularly preferred.
  • These heterocyclic rings may be substituted by the same substituents applied to the heterocyclic rings shown by Q in formula (II).
  • The divalent linkage group shown by A3 in formula (Ib) is a divalent linkage group composed of an atom or an atomic group selected from hydrogen, carbon, nitrogen, oxygen, and sulfur. Examples thereof are those illustrated as the linkage groups of A1 and A2 in formula (Ia) and a straight chain or branched alkinylene group (e.g., -CH-C=C-CH-). The linkage group shown by A3 may further comprise a linkage group by combinations of A1, A2 and/or an alkinylene group ,
    Figure imgb0016
    Figure imgb0017
    Figure imgb0018
    Figure imgb0019
    Figure imgb0020
  • The alkali metal shown by M1 in formula (Ib) includes Na+, K+, Li+, etc. The alkaline earth metal shown by M, includes Ca , Mg , etc. The quaternary ammonium salt shown by M1 has from 4 to 30 carbon atoms and examples thereof include, (CH3)4N, (C2H5)4N, (C4H9)4N, C6H5CH2N(CH3)3, and C16H33N(CH3)3. Also, examples of the quaternary phosphonium salt include (C4H9)4P, C16H33P(CH3)3, and C6H5CH2P(CH3)3.
  • The group shown by Mi, which can be replaced with hydrogen or an alkali metal atom under alkali conditions include an acetyl group, a cyanoethyl group, a methanesulfonylethyl group, etc.
  • Specific examples of the compound shown by formula (Ia) are illustrated below but the invention is not limited to these examples.
    Figure imgb0021
    Figure imgb0022
    Figure imgb0023
    Figure imgb0024
    Figure imgb0025
    Figure imgb0026
    Figure imgb0027
    Figure imgb0028
    Figure imgb0029
    Figure imgb0030
    Figure imgb0031
    Figure imgb0032
    Figure imgb0033
    Figure imgb0034
    Figure imgb0035
    Figure imgb0036
    Figure imgb0037
    Figure imgb0038
    Figure imgb0039
    Figure imgb0040
    Figure imgb0041
    Figure imgb0042
    Figure imgb0043
    Figure imgb0044
    Figure imgb0045
    Figure imgb0046
    Figure imgb0047
    Figure imgb0048
    Figure imgb0049
    Figure imgb0050
    Figure imgb0051
    Figure imgb0052
    Figure imgb0053
    Figure imgb0054
    Figure imgb0055
    Figure imgb0056
    Figure imgb0057
    Figure imgb0058
    Figure imgb0059
    Figure imgb0060
    Figure imgb0061
    Figure imgb0062
    Figure imgb0063
    Figure imgb0064
    Figure imgb0065
    Figure imgb0066
  • Specific examples of the compound of formula (Ib) are illustrated below but the invention is not limited to these compounds.
  • Figure imgb0067
    Figure imgb0068
    Figure imgb0069
    Figure imgb0070
    Figure imgb0071
    Figure imgb0072
    Figure imgb0073
    Figure imgb0074
    Figure imgb0075
    Figure imgb0076
    Figure imgb0077
    Figure imgb0078
    Figure imgb0079
    Figure imgb0080
    Figure imgb0081
    Figure imgb0082
    Figure imgb0083
    Figure imgb0084
    Figure imgb0085
    Figure imgb0086
    Figure imgb0087
    Figure imgb0088
    Figure imgb0089
    Figure imgb0090
    Figure imgb0091
    Figure imgb0092
    Figure imgb0093
    Figure imgb0094
    Figure imgb0095
    Figure imgb0096
    Figure imgb0097
    Figure imgb0098
    Figure imgb0099
    Figure imgb0100
    Figure imgb0101
    Figure imgb0102
    Figure imgb0103
    Figure imgb0104
    Figure imgb0105
    Figure imgb0106
    Figure imgb0107
    Figure imgb0108
    Figure imgb0109
    Figure imgb0110
    Figure imgb0111
    Figure imgb0112
    Figure imgb0113
  • The nucleation accelerators shown by formulae (Ia) and (Ib) are readily synthesized by the methods described in Berichte der Deutschen Chemischen Gesellschaft, 28, 77(1895), ibid., 22, 568 (1889), ibid., 29, 2483(1896), Journal of Chemical Society, 1932, 1806, Journal of The American Chemical Society, 71, 4000-(1949), Advances in Heterocyclic Chemistry, 9, 165(1968), Organic Synthesis, IV, 569(1963), Journal of The American Chemical Society, 45, 2390(1923), Chemische Berichte, 9, 465(1976), JP-A-50-37436 and JP-A-51-3231, U.S. Patents 3,295,976, 3,376,310, 2,585,388, and 2,541,924, JP-B-40-28496, JP-B-43-41353, JP-B-60-29390, JP-B-60-29391, JP-B-60-133061, and JP-B-61-1431 (the term "JP-B" as used herein means an "examined published Japanese patent application"), U.S. Patents 3,106.467, 3,420.670, 2,271,229, 3.137,578, 3,148,066, 3,511,663, 3,060,028, 3,271,154. 3.251,691, 3,598,599, 3.148,066, 3,615,616, 3.420.664, 3,071,465, 2,444,605, 2,444.606, 2,444,607, and 2,935,404, and JP-A-50-89034, JP-A-57-202531, JP-A-57-167023, JP-A-57-164735, JP-A-60-80839, JP-A-58-152235, JP-A-57-14836, JP-A-59-162546, JP-A-60-130731, JP-A-60-138548, JP-A-58-83852, JP-A-58-159529, JP-A-59-159162, JP-A-60-217358, and JP-A-61-80238.
  • These accelerators may be used singly or in combination thereof.
  • The hydrazine derivative for use in the present invention includes those having a sulfinyl group as described in U.S. Patent 4,478,928 and the compound shown by formula (IX). R2-NHNH-CHO (IX) wherein R2, represents an aliphatic group or an aromatic group.
  • The aliphatic group shown by R21 in formula (IX) is preferably an aliphatic group having from 1 to 30 carbon atoms. A straight chain, branched, or cyclic alkyl group having from 1 to 20 carbon atoms is preferred. The branched alkyl group may be cyclized so as to form a saturated heterocyclic ring containing at least one hetero atom. Also, the aforesaid alkyl group may have a substituent such as an aryl group, an aikoxy group, a sulfoxy group, a sulfonamido group, a carbonamido group, etc.
  • Examples thereof are t-butyl, n-octyl, t-octyl, cyclohexyl, pyrrolidyl, imidazolyl, tetrahydrofuryl, and morpholino.
  • The aromatic group shown by R21 in formula (IX) is a monocyclic or dicyclic aryl group or an unsaturated heterocyclic group. The unsaturated heterocyclic group may be condensed with a monocyclic or dicyclic aryl group to form a heteroaryl group.
  • Examples thereof are a benzene ring, a naphthalene ring, a pyridine ring, a pyrimidine ring, an imidazole ring, a pyrazole ring, a quinoline ring, an isoquinoline ring, a benzimidazole ring, a thiazole ring, and a benzothiazole ring. Among them, the groups having a benzene ring are preferred.
  • R21 is a particularly preferred aryl group.
  • The aryl group or aromatic group shown by R21 may be substituted. Typical examples of the substituent include a straight chain, branched, or cyclic alkyl group (preferably having from 1 to 20 carbon atoms), an aralkyl group (preferably a monocyclic or dicyclic ring the alkyl moiety of which has from 1 to 3 carbon atoms), an alkoxy group (preferably having from 1 to 20 carbon atoms), a substituted amino group (preferably an amino group substituted by an alkyl group having from 1 to 20 carbon atoms), an acylamino group (preferably having from 2 to 30 carbon atoms), a sulfonamido group (preferably having from 1 to 30 carbon atoms) and a ureido group (preferably having from 1 to 30 carbon atoms).
  • R21 in formula (IX) may have therein a ballast group being usually used to immobilize photographic additives such as couplers, etc. The ballast group is a group having at least 8 carbon atoms and is relatively inert to photographic properties. Examples thereof include an alkyl group, an alkoxy group, a phenyl group, an alkylphenyl group, a phenoxy group, and an alkylphenoxy group.
  • R21 in formula (IX) may have therein a group for enhancing the adsorption onto the surface of silver halide grains. Such adsorptive groups include a thiourea group, a heterocyclic thioamido group, a mercaptoheterocyclic group, a triazole group, etc., as disclosed in U.S. Patent 4,385,108.
  • Synthesis methods for the compounds shown by formula (IX) are disclosed in JP-A-53-20921, JP-A-53-20922, JP-A-53-66732, JP-A-53-20318, etc.
  • Specific examples of the compound shown by formula (IX) are illustrated below, but the invention is not limited to these compounds.
    Figure imgb0114
    Figure imgb0115
    Figure imgb0116
    Figure imgb0117
    Figure imgb0118
    Figure imgb0119
    Figure imgb0120
    Figure imgb0121
    Figure imgb0122
    Figure imgb0123
    Figure imgb0124
    Figure imgb0125
    Figure imgb0126
    Figure imgb0127
    Figure imgb0128
    Figure imgb0129
    Figure imgb0130
    Figure imgb0131
    Figure imgb0132
    Figure imgb0133
    Figure imgb0134
    Figure imgb0135
    Figure imgb0136
    Figure imgb0137
    Figure imgb0138
    Figure imgb0139
    Figure imgb0140
    Figure imgb0141
    Figure imgb0142
    Figure imgb0143
    Figure imgb0144
    Figure imgb0145
    Figure imgb0146
    Figure imgb0147
    Figure imgb0148
  • Other examples of the compound shown by formula (IX) are the following compounds disclosed in U.S. Patent 4,478,928.
    Figure imgb0149
    Figure imgb0150
    Figure imgb0151
  • In the present invention, particularly preferred compounds of formula (IX) have therein a group which enhances adsorption onto the surface of silver halide grains. Such adsorptive groups include a thiourea group, a heterocyclic thioamido group, a mercaptoheterocyclic group, a triazole group, etc. as disclosed in U.S. Patent 4,385,108. The preferred substituents for the aryl group or aromatic group shown by R1 include an amido group, a ureido group, a thiourea group, etc. A sulfonamido group is particularly preferred.
  • The nucleation accelerator and the hydrazine derivative of the present invention are preferably incorporated in a silver halide emulsion layer, but they may also be incorporated in other light-insensitive hydrophilic colloid layers (e.g., protective layer, interlayer, filter layer, antihalation layer, etc.), preferably those adjacent to a silver halide emulsion layer. They may be added in the same layer or different layers. Water soluble compound of formulae (la), (Ib) and (IX) may be added to the hydrophilic colloid solution as an aqueous solution thereof. Conversly, when the compound is sparingly soluble in water, the compound may be added thereto as a solution in an organic solvent which is miscible with water. Examples of solvent include water, methanol, ethanol, acetone, dimethylformamide, methylcellosolve, etc. When the compound of formula (Ia), (Ib) or (IX) is incorporated into the silver halide emulsion layer, the addition may be performed at any optional time from the initiation of chemical ripening to just prior to coating, but the compound is preferably added thereto after chemical ripening is complete and prior to coating. It is particularly preferred to add the compound to the coating composition prepared for coating.
  • The optimal amount of the compounds of formula (la), (Ib) and (IX) are selected according to the grain size and the halogen composition of the silver halide emulsion, the method and extent of chemical sensitization, the relation between the layer(s) in which the compounds are incorporated and a silver halide emulsion, and the kind of an antifoggant.
  • The addition amount of the compound of formula (la) for use in the present invention is preferably from 5 mg/m2 to 500 mg;m2, and 10 mg/m2 to 250 mg/m2 is particularly preferred. Also, the addition amount of the compound of formula (Ib) is preferably from 1 mg/m2 to 250 mg/m2, and 3 mg/m2 to 150 mg/m2 is particularly preferred. Furthermore, the addition amount of the compound of formula (IX) is preferably from 1 mg/m2 to 300 mg/m2, and 2 mg/m2 to 200 mg/m2 is particularly preferred. Also, the compound of formula (IX) wherein R2' contains therein a group enhancing the adsorption onto the surface of silver halide grains is preferably added in an amount of from 2 mg/m2 to 100 mg/m2.
  • The photographic emulsion for use in the present invention may contain silver bromide, silver iodobromide, silver iodochlorobromide, silver chlorobromide, silver iodide, or silver chloride, but it is preferred that the silver halide contains at least 50 mol% silver chloride.
  • The silver halide grains in the photographic emulsion may have a regular crystal form such as cubic, octahedral, dodecahedral, tetradecahedral, etc.; an irregular crystal form such as sphere, tabular, etc.; or a composite of these crystal forms. The silver halide grains may be composed of a mixture of grains having various crystal forms.
  • The silver halide grains for use in the present invention may have different phase between the inside and the surface layer thereof or may be composed of a uniform phase throughout the whole grain.
  • During the During the formation or physical ripening of the silver halide grains, a cadmium salt, a zinc salt, a lead salt, a thallium salt, an iridium salt or a complex salt thereof, rhodium salt or a complex salt thereof, iron salt or a complex salt thereof, etc., may be present in the system.
  • Also, a silver halide solvent (e.g., ammonia, potassium rhodanate, and thioethers and thione compounds as described in U.S. Patent 3,271,157, JP-A-51-12360, JP-A-53-82408, JP-A-53-144319, JP-A-54-100717, and JP-A-54-155828) can be used as required in the present invention.
  • The silver halide emulsion for use in the present invention may or may not be chemically sensitized. Chemical sensitization for use in the present invention include a sulfur sensitization method using active gelatin or a sulfur-containing compound capable of reacting with silver (e.g., thiosulfates, thioureas, mercapto compounds, and rhodanines); a reduction sensitizing method using a reducing material e.g., stannous salt, amines, hydrazine derivatives, formamidinesulfinic acid, silane compounds, etc.); a noble metal sensitization method using a metal compound (e.g., gold complex salts and complex salts of noble metals belonging to group VIII of the Periodic Table, such as Pt, Ir, Pd, etc.); or a combination thereof.
  • The silver halide emulsions for use in this invention can contain various compounds for preventing the formation of fog during the storage and/or photographic processing of the light-sensitive material or for stabilizing photographic performance. For example, such antifoggants or stabilizers include azoles (e.g., benzothiazoliums, nitroindazoles, triazoles, benzotriazoles, benzimidazoles (in particular, nitro- or halogen- substituted benzimidazoles)); heterocyclic mercapto compounds (e.g., mercaptothiazoles, mercaptobenzothiazoles, mercaptobenzimidazoles, mercaptothiadiazoles, mercaptotetrazoles (in particular, 1-phenyl-5-mercaptotetrazole), and mercaptopyrimidines), the aforesaid heterocyclic mercapto compounds having a water-solubilizing group such as a carboxy group and a sulfon group, thioketo compounds (e.g. ox- azolinethione), azaindenes (e.g., tetraazaindenes (in particular, 4-hydroxy-substituted (1.3,3a.7)-tetraazaindenes), benzenethiosulfonic acids, and benzenesulfinic acid.
  • The photographic emulsion for use in the present invention may be spectrally sensitized to relatively a long wavelength of blue light, green light, red light, or infrared light using sensitizing dyes. Such sensitizing dyes include cyanine dyes, merocyanine dyes, complex cyanine dyes, complex merocyanine dyes, holopolar cyanine dyes, styryl dyes, hemicyanine dyes, oxonol dyes, hemioxonol dyes, etc.
  • Practical examples of the spectral sensitizing dyes and disclosed in, for example, P. Glafkides, Chemie Photographique, 2nd edition, Chapters 35 to 41, published by Paul Montel, Paris, 1957, F.M. Hamer, The Cyanine anc Related Compound, Interscience, U.S. Patents 2,503,776, 3,459,553, and 3,177,210, and Research Disclosure, Vol. 176, No. 17643, Paragraph 23, IV-J, (December, 1978).
  • The photographic light-sensitive material being processed in the present invention may contain water-soluble dyes in the hydrophilic colloid layer(s) as filter dyes or for irradiation inhibition, etc. Such dyes include oxonol dyes, hemioxonol dyes, styryl dyes, merocyanine dyes, cyanine dyes and azo dyes. Among them, oxonol dyes, hemioxanol dyes, and merocyanine dyes are particularly useful.
  • Also, the photographic light-sensitive material of the present invention may further contain in the photographic emulsion layer(s) and other hydrophilic colloid layer(s) an inorganic or organic hardening agent. For example, active vinyl compounds (e.g., 1,3,5-triacryloyl-hexahydro-s-triazine and 1,3- vinylsulfonyl-2-propanol) and active halogen compounds (e.g., 2,4-dichloro-6-hydroxy-s-triazine) can be used singly or as a combination thereof.
  • Furthermore, the photographic light-sensitive material of the present invention may further contain in the photographic emulsion layer(s) or other hydrophilic colloid layer(s) various surface active agents.
  • Examples of surface active agent for use in the present invention are nonionic surface active agents such as saponin (steroid series), alkylene oxide derivatives (e.g., polyethylene glycol, polyethylene glycolipolypropylene glycol condensates, polyethylene glycol alkyl ethers, polyethylene glycol alkylaryl ethers, polyethylene glycol esters, polyethylene glycol sorbitan esters, polyalkylene glycol alkylamines, polyalkylene glycol alkylamides, and polyethylene oxide addition products of silicone), glycidol derivatives (e.g., alkenyl succinic acid polyglyceride and alkylphenol polyglyceride), aliphatic acid esters of polyhydric alcohols, alkyl esters of saccharide, etc.; anionic surface active agents containing an acid group (e.g., a carboxy group, a sulfo group, a phospho group, a sulfuric acid ester group, and a phosphoric acid ester group), such as alkyl carboxylates, alkyl sulfonates, alkylbenzenesulfonates, alkylnaphthalenesulfonates, alkylsulfuric acid esters, alkylphosphoric acid esters, N-acyl-N-alkyltaurins, sulfosuccinic acid esters, sulfoalkyl polyoxyethylene alkylphenyl ethers, polyoxy ethylene alkylphosphoric acid esters, etc.; amphoteric surface active agents such as amino acids, aminoalkylsulfonic acids, aminoalkylsulfuric acid esters, aminoalkylphosphoric acid esters, alkylbetaines, amine oxides, etc.; and cationic surface active agents such as alkylamine salts, aliphatic quaternary ammonium salts, aromatic quaternary ammonium salts, heterocyclic quaternary ammonium salts (e.g., pyridinium and imidazolium), phosphonium or sulfonium salts containing an aliphatic or aromatic ring, etc.
  • The photographic emulsion layer(s) of the photographic light-sensitive material of the present invention may further contain polyalkylene oxide or the derivatives thereof such as the ethers, esters, amines, etc., thereof, thioether compounds, thiomorpholines, quaternary ammonium salt compounds, urethane derivatives, urea derivatives, imidazole derivatives, 3-pyrazolidone derivatives, etc., for increasing sensitivity, contrast, and/or accelerating development.
  • As the binder or protective colloid for the emulsion layer(s) and other hydrophilic colloid layer(s) of the photographic light-sensitive material of the present invention, gelatin is advantageously used, but other hydrophilic colloids can also be used.
  • For example, hydrophilic high molecular materials such as polyvinyl alcohol, polyvinyl alcohol partial acetal, poly-N-vinylpyrrolidone, polyacrylic acid, polyacrylamide, dextran, etc. may be used.
  • In order to obtain photographic characteristics of super high contrast using the silver halide photographic material of the present invention, a stable developer can be used without use of either a conventional infectious developer or a high alkaline developer of about pH 13 as described in U.S. Patent 2,419.975.
  • That is, using the process of the present invention, super high contrast negative images are obtained by processing the light-sensitive material of the present invention with a developer containing a sulfite ion at a concentration of at least 0.15 mol/liter and having pH of from 9.6 to 11.0, and particularly from 10.0 to 11.0.
  • There is no particular restriction on the developing agent which can be used in the process of the present invention and, for example, dihydroxybenzenes (e.g., hydroquinone), 3-pyrazolidones (e.g., 1-phenyl-3-pyrazolidone, 4,4-dimethyl-1-phenyl-3-pyrazolidone), and aminophenols (e.g., N-methyl-p-aminophenol) can be used singly or in combination thereof.
  • The silver halide light-sensitive material of the present invention is preferably processed by a developer containing a dihydroxybenzene as the primary developing agent and a 3-pyrazolidone or an aminophenol as an auxiliary developing agent. In this case, it is preferred that the developer contain the dihydroxybenzene in the range of from 0.05 to 0.5 mol;liter and the 3-pyrazolidone or aminophenol in the range of less than 0.06 mol/liter.
  • Also, as disclosed in U.S. Patent 4,269,929, by adding an amine to the developer, the developing speed can be increased to thus shorten the development time.
  • The developer for use in the present invention may further contain pH buffers such as sulfites, carbonates, borates, and phosphates of an alkali metal or a development inhibitors or antifoggants such as bromides, iodides and organic antifoggants (nitroindazoles or benzotriazoles are particularly preferred). Also, if necessary, the developer may contain a water softener, a resolution aid, a toning agent, a development accelerator, a surface active agent (a polyalkylene oxide is particularly preferred), a defoaming agent, a hardening agent, and or a silver stain inhibitor of films (e.g., 2-mercaptobenzimidazole sulfonic acids).
  • After development, the silver halide light-sensitive material is fixed in the present invention. Ordinary fixing compositions can be employed including thiosulfates, thiocyanates, and organic sulfur compounds which are known to have an effect as fixing agent. The fix solution may contain a water-soluble aluminum salt as a hardening agent.
  • The processing temperature in the process of the present invention is typically from 18° C to 50 C.
  • An automatic processor is preferably used for the photographic processing of the present invention. Even when the total processing time is in the range of from 90 seconds to 120 seconds., negative photographic characteristics of super high contrast are obtained.
  • The developer for use in the present invention may contain the compound disclosed in JP-A-56-24347 as a silver stain inhibitor. Furthermore, the developer may contain the compound disclosed in JP-A-61-267759 as a resolution aid. Moreover, the developer may further contain the compound disclosed in JP-A-60-93433 or boron compounds disclosed in JP-A-62-186259.
  • The following examples are intended to illustrate the present invention but not to limit it in any way.
  • A silver chloroiodobromide emulsion (containing 0.1 mol% silver iodide and 30 mol% silver bromide) was prepared using a double jet method as shown below. For preparing the silver chloroiodobromide emulsion, (NH4)3RhCl6 was added to the aqueous halide solution (containing KBr, NaCt and KI)as a rhodium salt at a concentration of 5x10-6 mol/mol-Ag. K3IrCl6 was also added to the aqueous halide solution as an iridium salt at a concentration of 4x10-7 mol/mol-Ag.
  • The aqueous halide solution thus prepared and an aqueous silver nitrate solution were added to an aqueous gelatin solution and mixed for 60 minutes at 45°C to provide a mono-dispersed cubic grain size halide having a mean grain size of 0.25 µm. After washing the emulsion with water and desalting, 1x10-5 mol/mol-Ag of sodium thiosulfate and 1x10-5 mol/mol-Ag of potassium chloroaurate were added to the emulsion for gold sensitization. To the emulsion were further added 3x10-4 mol/mol-Ag of 1-(2-hydroxyethoxyethyl)-3-(pyridin-2-yl)-5-[(3-sulfobutyl-5-chloro-2-benzoxazolinidene)ethylidene]-2-thiohydantoin potassium salt as a sensitizing dye, 1.5 g of 4-hydroxy-6-methyl-1,3,3a,7-tetraazaindene as a stabilizer, 2 g of hydroquinone, 2 g of resorcin aldoxium, and 0.1 g of 1-phenyl-5-mercaptotetrazole each per mol of silver.
  • Furthermore, to the emulsion were added the compound of formula
    Figure imgb0152
    and saponin as coating aids, the compound of formula CH2=CHSO2CH2CONH-(CH2)-nNHCOCH2SO2CH=CH2 (n = 2 or 3) as a hardening agent, sodium polystyrenesulfonate as a tackifier, and a dispersion of polyethyl acrylate as a latex polymer.
  • Moreover, to the emulsion were further added each of IX-9, IX-31, IX-20, IX-32, IX-34, and IX-35 as the hydrazine compound shown by formula (IX) and each of la-15 and Ib-7 as a nucleation accelerator as shown in Table 1 below to provide the silver halide emulsion.
  • A coating composition for a protective layer was composed of an aqueous gelatin solution containing gelatin, sodium dodecylbenzenesulfonate, colloidal silica, a dispersion of polyethyl acrylate, polymethyl methacrylate (matting agents), and sodium polystyrenesulfonate (tackifier).
  • The aforesaid emulsion and the coating composition for the protective layer were simultaneously coated on a transparent plastic film support at a gelatin coverage of 1.6 gim2 for the protective layer and a silver coverage of 3.6 g/m2 for the emulsion layer.
  • Each sample thus prepared was exposed to tungsten light of 3200 K through a sensitometric optical wedge for 5 seconds, developed by developer (A) or (D) having the composition shown below for 30 seconds at 38 C, fixed, washed, and dried. An automatic processor FG-660F, made by Fuji Photo Film Co., Ltd. was used for the development processing.
    Figure imgb0153
  • Developer (D) was prepared by adding acetic acid to developer (A) reducing the pH to 10.4.
  • Then, the G value of each sample thus processed was measured and the results obtained are shown in Table 1.
  • The G value is calculared by the equation G=[3.0-0.3]/ΔlogE wherein ΔlogE is the difference in the exposure amounts (logE) necessary to attain the densities of 3.0 and 0.3, respectively.
  • Also, after placing 1 liter of each of the developers (A) and (D) in a one liter beaker and aged at room temperature and open to air for one week, the aforesaid sample was processed by the developer as described above and the G value was measured. The results are also shown in Table 1.
  • From the results shown in Table 1, it can be seen that by using the nucleation accelerator of the present invention, the G value is above 10, even at low developer pH. Also, development processing is stable as shown by the small difference in G value when using 1 week old developer.
    Figure imgb0154
    Figure imgb0155
  • EXAMPLE 2
  • Developers (B), (C), (D), (E), (F), and (G) were prepared having the same composition as the developer in Example 1 except that the pH value was adjusted as shown in Table 2. Light-sensitive film prepared as in Sample No. 9 of Example 1 was processed using the developer of Example 1, as adjusted for pH, and the G value was then measured. The results are shown in Table 2. After placing one liter of each of the developers (A) to (G) in a one liter beaker and allowing to age at room temperature and open to air for one week, the light-sensitive film was processed using the one week old developer and the G value was measured. The results are also shown in Table 2.
    Figure imgb0156
  • From the results in Table 2, it can be seen that by using the compounds of the present invention, a super high contrast value of at least a G of 10 is obtained and the G value remains stable, using aged developer, in the claimed pH range.
  • EXAMPLE 3
  • The same procedure was followed as for Sample No. 9 in Example 1 except that each of la-16 and la-21 was added in place of la-15 to prepare Sample Nos. 26 and 27. Each sample was processed as in Example 1 and the G value was measured. The results are shown in Table 3.
    Figure imgb0157
  • From the results above, it can be seen that by using the compounds in the present invention, a super high contrast of G greater than 10 is obtained at low pH and processing stability is maintained in the case of using the developer of low pH.
  • EXAMPLE 4
  • Developers (A), (B), (C), (D), (E), (F), and (G) were prepared as in Example 2. Also, by following the same procedure as Sample 23 in Example 1, a light-sensitive material was prepared, processed as in Example 1 using the developers (A) to (G) and the G value was measured. The results are shown in Table
    • 4. Also, after placing one liter of each of the developers (A) to (G) in a one liter beaker and exposing the developer to air at room temperature for one week, the samples were processed as above using the developers (A) to (G) and the Gvalue was measured. The results are shown in Table 4.
      Figure imgb0158
  • From the results shown above, it can be seen that by using the compounds in this invention, a super high contrast of G at least 10 is obtained, and the G value remains stable, using aged developer, in the claimed pH range.
  • EXAMPLE 5
  • By following the same procedure as Sample No. 23 in Example 1 except that each of Ib-10 and Ib-31 was used in place of Ib-7 as the nucleating accelerator. Sample Nos. 28 and 29 were prepared. Each sample was processed as in Example 1 and the G value was measured. The results are shown in Table 5. Also, the developer was aged for one week as in Example 1, each sample was processed using the developers (A) and (B), and the G value was measured. The results are shown in Table 5.
    Figure imgb0159
  • As shown in the above results, it can be seen that by using the compounds of the present invention, super high contrast of G value greater than 10 is obtained, and the G value remains stable and stability can be kept when using a developer having low pH.
  • While the invention has been described in detail and with reference to specific embodiments thereof, it will be apparent to one skilled in the art that various changes and modifications can be made therein without departing from the spirit and scope thereof.

Claims (19)

1. a process for forming super high contrast negative images, which comprises processing a super high contrast negative type silver halide photographic material comprising a support having thereon at least one layer, one of which must be a silver halide emulsion layer, said silver halide emulsion layer or other hydrophilic colloid layer containing at least one hydrazine derivative and at least one nucleation accelerator represented by following formula (la) or (Ib) with a developer having a pH of from 9.6 to 11.0; Y[(A1)pA2-B]m (Ia) M· S(X)nA3-B (Ib) wherein Y represents a group adsorbing onto silver halide; A1 represents a divalent linkage group composed of an atom or an atomic group selected from hydrogen, carbon, nitrogen, oxygen, and sulfur; A2 represents a divalent linkage group; A3 represents a linkage group composed of an atom or an atomic group selected from carbon, nitrogen, oxygen, and sulfur; B represents a substituted or unsubstituted amino group, an ammonium group, or a nitrogen-containing heterocyclic ring; X represents a divalent heterocyclic ring containing nitrogen, oxygen, selenium or sulfur; M, represents a hydrogen atom, an alkali metal, an alkaline earth metal, a quaternary ammonium salt, a quaternary phosphonium salt, an amidino group, or a group capable of being released under an alkali condition; m represents the integer 1, 2, or 3; and n and p each represents 0 or the integer 1.
2. A process as in claim 1, wherein said Y absorbing group is a nitrogen-containing heterocyclic group such that said nucleation accelerator is represented by formula
Figure imgb0160
wherein Q represents an atomic group necessary for forming a 5- or 6-membered heterocyclic ring composed of members selected from carbon, nitrogen, oxygen and sulfur or the condensation product of said 5- or 6-membered ring with a carbon aromatic ring or a heteroaromatic ring; M2 represents hydrogen. an alkali metal atom, an ammonium group or a group capable of being replaced with hydrogen or an alkali metal atom under alkali conditions; and t represents 0 or the integer 1.
3. A process as in claim 2, wherein said nitrogen-containing heterocyclic group comprises a substituted or unsubstituted indazole, benzimidazole, benzoriazole, benzoxazole, benzthiazole, imidazole, thiazole. oxazole, triazole, tetrazole, azaindene, pyrazole, indole, triazine, pyrimidine, pyridine or quinoline.
4. A process as in claim 2, wherein said M2 releasing group is acetyl, cyanoethyl or methanesulfonylethyl.
5. A process as in claim 1, wherein said divalent linkage group A, is
Figure imgb0161
Figure imgb0162
Figure imgb0163
or a combination thereof with a straight chain or branched alkylene group wherein R,, R2, R3, R4, Rs, R6, R7, Rs, Rg and R10 each represents hydrogen, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted alkenyl group or a substituted or unsubstituted aralkyl group.
6. A process as in claim 1, wherein said divalent linkage group A2 is a straight chain or branched alkylene group, a straight chain or branched alkenylene group, a straight chain or branched aralkylene group or a straight chain or branched arylene group.
7. A process as in claim 1, wherein said divalent heterocyclic ring X comprises a substituted or unsubstituted tetrazole, triazole, thiadiazole, oxadiazole, selenadiazole, imidazole, thiazole, oxazole, benzimidazole, benzthiazole, benzoxazole, benzselenazole or pyrimidine.
8. A process as in claim 1, wherein said divalent linkage group A3 is
Figure imgb0164
Figure imgb0165
Figure imgb0166
or a combination thereof with a straight chain or branched alkylene group and/or a straght chain or branched alkinylene group wherein R1, R2, R3, R4, R5, R6, R7, Rs, Rg and R10 each represents hydrogen, a substituted or unsubstituted alkyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted alkenyl group or a substituted or unsubstituted aralkyl group.
9. A process as in claim 1, wherein said M, releasing group is acetyl, cyanoethyl or methanesulfonylethyl.
10. A process as in claim 1, wherein said B nitrogen-containing heterocyclic ring is imidazolyl, pyridyl or thiazolyl.
11. A process as in claim 2, wherein said nucleation accelerator is represented by the formula
Figure imgb0167
12. A process as in claim 2, wherein said nucleation accelerator is represented by the formula
Figure imgb0168
13. A process as in claim 2, wherein said nucleation accelerator is represented by the formula
Figure imgb0169
14. A process as in claim 2, wherein said nucleation accelerator is represented by the formula
Figure imgb0170
wherein Z1, Z2, and Z3 each represents (A, )pA2-B or a halogen atom. an alkoxy group having from 1 to 20 carbon atoms, a hydroxy group, a hydroxyamino group or a substituted or unsubstituted amino group provided that at least one of Z1, Z2, and Z3 is (A, )pA2-B.
15. A process as in claim 1, wherein said hydrazine derivative is represented by the formula R2-NHNH-CHO wherein R21 is an aliphatic group having from 1 to 30 carbon atoms or an aromatic group comprising a monocyclic or dicyclic aryl group, unsaturated heterocyclic group or the condensation product of the unsaturated heterocyclic group with the monocyclic or dicyclic aryl group.
16. A process as in claim 1, wherein said nucleation accelerator of formula (la) is added in an amount of from 5 mg/m2 to 500 mg/m2 to said photographic material.
17. A process as in claim 1, wherein said nucleation accelerator of formula (Ib) is added in an amount of from 1 mg/m2 to 250 mg/m2 to said photographic material.
18 A Process as in claim 1, wherein said hydrazine derivative is added in an amount of from 1 mg/m2 to 300 mg/m2.
19. A process as in claim 1, wherein said developer contains sulfite ion at a concentration of at least 0.15 mol/liter.
EP89100317A 1988-01-11 1989-01-10 Process for forming super high contrast negative images Expired - Lifetime EP0324426B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP63003446A JPH01179940A (en) 1988-01-11 1988-01-11 Method for forming ultrahigh contrast negative image
JP3445/88 1988-01-11
JP3446/88 1988-01-11
JP63003445A JPH01179939A (en) 1988-01-11 1988-01-11 Method for forming ultrahigh contrast negative image

Publications (3)

Publication Number Publication Date
EP0324426A2 true EP0324426A2 (en) 1989-07-19
EP0324426A3 EP0324426A3 (en) 1990-12-12
EP0324426B1 EP0324426B1 (en) 1996-06-19

Family

ID=26337019

Family Applications (1)

Application Number Title Priority Date Filing Date
EP89100317A Expired - Lifetime EP0324426B1 (en) 1988-01-11 1989-01-10 Process for forming super high contrast negative images

Country Status (2)

Country Link
EP (1) EP0324426B1 (en)
DE (1) DE68926687T2 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0397167A2 (en) * 1989-05-10 1990-11-14 Fuji Photo Film Co., Ltd. Method of forming images
US5200298A (en) * 1989-05-10 1993-04-06 Fuji Photo Film Co., Ltd. Method of forming images
US5407792A (en) * 1993-04-10 1995-04-18 E. I. Du Pont De Nemours And Company Photosensitive silver halide recording material with reduced pressure sensitivity
DE19522725A1 (en) * 1994-06-24 1996-01-04 Mitsubishi Paper Mills Ltd Photographic silver halide material
US6218070B1 (en) 1993-03-30 2001-04-17 Agfa-Gevaert, N.V. Process to make ultrahigh contrast images
EP1260858A2 (en) * 2001-05-25 2002-11-27 Fuji Photo Film Co., Ltd. Image formation process
US7470699B2 (en) 2003-07-11 2008-12-30 Arena Pharmaceuticals, Inc. Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7812159B2 (en) 2005-01-10 2010-10-12 Arena Pharamaceuticals, Inc. Processes for preparing aromatic ethers
US8293751B2 (en) 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US8362248B2 (en) 2005-01-10 2013-01-29 Arena Pharmaceuticals, Inc. Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
US10894787B2 (en) 2010-09-22 2021-01-19 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
US11884626B2 (en) 2015-06-22 2024-01-30 Arena Pharmaceuticals, Inc. Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6230243A (en) * 1985-04-18 1987-02-09 Fuji Photo Film Co Ltd Silver halide photographic sensitive material and formation of negative image having high contrasity using its material
EP0249239A2 (en) * 1986-06-12 1987-12-16 Fuji Photo Film Co., Ltd. Process for the formation of direct positive images
JPH06230243A (en) * 1992-10-29 1994-08-19 Hughes Aircraft Co Distributed light network thermally insulated from central light source

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6230243A (en) * 1985-04-18 1987-02-09 Fuji Photo Film Co Ltd Silver halide photographic sensitive material and formation of negative image having high contrasity using its material
EP0249239A2 (en) * 1986-06-12 1987-12-16 Fuji Photo Film Co., Ltd. Process for the formation of direct positive images
JPH06230243A (en) * 1992-10-29 1994-08-19 Hughes Aircraft Co Distributed light network thermally insulated from central light source

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
RESEARCH DISCLOSURE. vol. 236, December 1983, HAVANT GB pages 382 - 383; R.Pollet et al.: "Benzamin:Preparation and use as stabilizers in silver halide materials ofbidentate heterocyclic compounds containing an aminogroup" *

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0397167A2 (en) * 1989-05-10 1990-11-14 Fuji Photo Film Co., Ltd. Method of forming images
EP0397167A3 (en) * 1989-05-10 1991-01-23 Fuji Photo Film Co., Ltd. Method of forming images
US5200298A (en) * 1989-05-10 1993-04-06 Fuji Photo Film Co., Ltd. Method of forming images
US6218070B1 (en) 1993-03-30 2001-04-17 Agfa-Gevaert, N.V. Process to make ultrahigh contrast images
US5407792A (en) * 1993-04-10 1995-04-18 E. I. Du Pont De Nemours And Company Photosensitive silver halide recording material with reduced pressure sensitivity
DE19522725A1 (en) * 1994-06-24 1996-01-04 Mitsubishi Paper Mills Ltd Photographic silver halide material
DE19522725C2 (en) * 1994-06-24 2000-04-13 Mitsubishi Paper Mills Ltd Silver halide photographic photosensitive material
EP1260858A3 (en) * 2001-05-25 2003-11-12 Fuji Photo Film Co., Ltd. Image formation process
EP1260858A2 (en) * 2001-05-25 2002-11-27 Fuji Photo Film Co., Ltd. Image formation process
US8293751B2 (en) 2003-01-14 2012-10-23 Arena Pharmaceuticals, Inc. 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
US7470699B2 (en) 2003-07-11 2008-12-30 Arena Pharmaceuticals, Inc. Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7838525B2 (en) 2003-07-11 2010-11-23 Arena Pharmaceuticals, Inc. Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
US7812159B2 (en) 2005-01-10 2010-10-12 Arena Pharamaceuticals, Inc. Processes for preparing aromatic ethers
US8362248B2 (en) 2005-01-10 2013-01-29 Arena Pharmaceuticals, Inc. Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
US10894787B2 (en) 2010-09-22 2021-01-19 Arena Pharmaceuticals, Inc. Modulators of the GPR119 receptor and the treatment of disorders related thereto
US11007175B2 (en) 2015-01-06 2021-05-18 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the S1P1 receptor
US11884626B2 (en) 2015-06-22 2024-01-30 Arena Pharmaceuticals, Inc. Crystalline L-arginine salt of (R)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta [b]indol-3-yl)acetic acid(Compound1) for use in S1P1 receptor-associated disorders

Also Published As

Publication number Publication date
EP0324426A3 (en) 1990-12-12
EP0324426B1 (en) 1996-06-19
DE68926687D1 (en) 1996-07-25
DE68926687T2 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
US5139921A (en) Process for forming super high contrast negative images
EP0267598B1 (en) Superhigh contrast negative-type silver halide photographic material
US4914003A (en) Silver halide photographic material and process for the formation of image using same
US4965169A (en) Method for forming a high contrast negative image
EP0292986B1 (en) Silver halide photographic materials
EP0324426B1 (en) Process for forming super high contrast negative images
US5030547A (en) Silver halide photographic material
JP3372365B2 (en) Silver halide photographic material and image forming method using the same
JP2604154B2 (en) Silver halide photographic material
JP2709646B2 (en) Silver halide photographic light-sensitive material and processing method thereof
JP2889960B2 (en) Silver halide photographic material
JP2887368B2 (en) Silver halide photographic material
US5238780A (en) Method of image formation
JPH0816777B2 (en) Image forming method
JP2995360B2 (en) Silver halide photographic material
JP2525585B2 (en) Ultra-high contrast negative type silver halide photosensitive material
JP2640126B2 (en) Silver halide photographic material
US5147755A (en) Silver halide photographic material
JP2618631B2 (en) Silver halide photographic material
JP2564170B2 (en) Silver halide photographic material
JP2709759B2 (en) Silver halide photographic material
JPH01179940A (en) Method for forming ultrahigh contrast negative image
JP2640273B2 (en) Silver halide photographic material
US6150083A (en) Photograhic silver halide material and process for preparing silver images
JPH01200245A (en) Silver halide photographic sensitive material

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): DE FR GB IT

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): DE FR GB IT

17P Request for examination filed

Effective date: 19910419

17Q First examination report despatched

Effective date: 19940311

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR GB IT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 19960619

Ref country code: FR

Effective date: 19960619

REF Corresponds to:

Ref document number: 68926687

Country of ref document: DE

Date of ref document: 19960725

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

EN Fr: translation not filed
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Effective date: 19970110

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 19970110

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20050106

Year of fee payment: 17

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20060801